These newly recruited cells, described as F4/80int CX3CR1int, become the dominant subset and support key pathogenic mechanisms in colitis through robust expression of TNFα and IL-23 and efficient activation of T cells through MHCII. The gene discussed is TNF; the disease is colitis.